Published in Int J Audiol on January 01, 2003
Plasticity at glycinergic synapses in dorsal cochlear nucleus of rats with behavioral evidence of tinnitus. Neuroscience (2009) 1.62
Inhibitory neurotransmission in animal models of tinnitus: maladaptive plasticity. Hear Res (2011) 1.19
Validity of the Italian adaptation of the Tinnitus Handicap Inventory; focus on quality of life and psychological distress in tinnitus-sufferers. Acta Otorhinolaryngol Ital (2008) 1.11
Assessment of psychopathological aspects and psychiatric comorbidities in patients affected by tinnitus. Eur Arch Otorhinolaryngol (2007) 0.99
Blast-induced tinnitus and hearing loss in rats: behavioral and imaging assays. J Neurotrauma (2011) 0.95
A scientific cognitive-behavioral model of tinnitus: novel conceptualizations of tinnitus distress. Front Neurol (2014) 0.93
Trauma-associated tinnitus: audiological, demographic and clinical characteristics. PLoS One (2012) 0.80
Tinnitus-related distress and the personality characteristic resilience. Neural Plast (2014) 0.77
The epworth sleepiness scale in the assessment of sleep disturbance in veterans with tinnitus. Int J Otolaryngol (2015) 0.76
The Correlation of the Tinnitus Handicap Inventory with Depression and Anxiety in Veterans with Tinnitus. Int J Otolaryngol (2015) 0.75
Theoretical Tinnitus Framework: A Neurofunctional Model. Front Neurosci (2016) 0.75
A brain centred view of psychiatric comorbidity in tinnitus: from otology to hodology. Neural Plast (2014) 0.75
Characterization of tinnitus in different age groups: A retrospective review. Noise Health (2016) 0.75
Personality Traits in Patients with Subjective Idiopathic Tinnitus. Iran J Otorhinolaryngol (2015) 0.75
Somatoform disorders in patients with chronic subjective tinnitus. Eur Arch Otorhinolaryngol (2016) 0.75
Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med (1999) 3.76
Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet (1998) 2.72
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene (2008) 2.29
The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res (1985) 2.14
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology (2006) 2.11
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ (2004) 1.82
A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J (1992) 1.81
Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. Proc Natl Acad Sci U S A (1984) 1.80
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J (1997) 1.51
Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies. Cancer Lett (1992) 1.46
Neonatal diabetes and DQB1 typing. Diabetes Care (1996) 1.43
Lipoid proteinosis: case report and review of the literature. Acta Otorhinolaryngol Ital (2006) 1.42
Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene (1995) 1.41
Identification, nucleotide sequence and expression of the regulatory region of the histidine operon of Escherichia coli K-12. Nucleic Acids Res (1981) 1.41
[A mortality study of recipients of compensation for asbestosis in Italy (1980-1990)]. Med Lav (1997) 1.38
The Gatehouse Project: a systematic approach to mental health promotion in secondary schools. Aust N Z J Psychiatry (2000) 1.35
Urokinase-dependent cell surface proteolysis and cancer. Semin Cancer Biol (1990) 1.30
Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate. J Cell Biol (1986) 1.23
A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann Neurol (2000) 1.22
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene (2007) 1.18
Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology (1999) 1.16
McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry (2010) 1.16
In vivo regulation of oxidative phosphorylation in cells harboring a stop-codon mutation in mitochondrial DNA-encoded cytochrome c oxidase subunit I. J Biol Chem (2001) 1.16
Lysis protein S of phage lambda functions in Saccharomyces cerevisiae. J Bacteriol (1990) 1.15
Long-term survival in Stuve-Wiedemann syndrome: a neuro-myo-skeletal disorder with manifestations of dysautonomia. Am J Med Genet A (2003) 1.15
Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med (2002) 1.11
Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor. Proc Natl Acad Sci U S A (1984) 1.10
FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res (2000) 1.10
Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA. Neurology (1998) 1.09
SPG3A: An additional family carrying a new atlastin mutation. Neurology (2002) 1.07
Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies. Neurology (2010) 1.07
Outbreak of listerosis due to imported cooked ham, Switzerland 2011. Euro Surveill (2013) 1.05
Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Health (2000) 1.05
Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene (1998) 1.03
Gadolinium-enhanced MR imaging in the differential diagnosis of placenta accreta and placenta percreta. Radiology (2000) 1.02
High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. J Neurol Sci (1996) 1.02
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study. Neuromuscul Disord (2006) 1.01
A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol (1999) 1.00
Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. Neurology (1998) 1.00
Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry (1998) 0.99
Role of topical and nutritional supplement to modify the oxidative stress. Int J Cosmet Sci (2002) 0.98
Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology (2000) 0.98
Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann Neurol (1999) 0.97
Radicular compression by lumbar intraspinal epidural gas pseudocyst in association with lateral disc herniation. Role of the posterior longitudinal ligament. J Neurosurg Sci (2002) 0.95
Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord (2003) 0.95
Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum Mutat (2001) 0.94
Muscle MRI in TRPV4-related congenital distal SMA. Neurology (2012) 0.93
Financing student education in the future. Br Dent J (2005) 0.92
Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder. AJNR Am J Neuroradiol (2007) 0.92
Systematic reviews of clinical decision tools for acute abdominal pain. Health Technol Assess (2006) 0.92
Transcriptional induction of urokinase in cultured human kidney carcinoma cells by tetradecanoyl-phorbol-acetate. J Cell Physiol (1984) 0.92
Human urokinase gene is located on the long arm of chromosome 10. Proc Natl Acad Sci U S A (1985) 0.92
Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation. Cancer Res (2001) 0.92
Congenital muscular dystrophy with defective alpha-dystroglycan, cerebellar hypoplasia, and epilepsy. Neurology (2009) 0.90
Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1. Epidemiol Infect (1991) 0.89
Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency. Clin Genet (2011) 0.89
Covalent linking of haptens, proteins and nucleic acids to a modified polystyrene support. J Immunol Methods (1993) 0.89
Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia (2004) 0.89
Expanding the clinical spectrum of POMT1 phenotype. Neurology (2006) 0.88
Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions. Eur J Neurol (2008) 0.88
McArdle disease: molecular genetic update. Acta Myol (2007) 0.88
Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5. Acta Paediatr (2010) 0.88
Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry (2002) 0.88
The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study. Neuromuscul Disord (2007) 0.88
Congenital muscular dystrophies with cognitive impairment. A population study. Neurology (2010) 0.88
Phenotypic heterogeneity in two unrelated Danon patients associated with the same LAMP-2 gene mutation. Neuropediatrics (2005) 0.88
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. J Neurol Sci (2001) 0.88
Allogeneic bone marrow transplantation for Pearson's syndrome. Bone Marrow Transplant (2007) 0.87
Cohort mortality study of women compensated for asbestosis in Italy. Am J Ind Med (1999) 0.87
[The mortality among the makers of vinyl chloride in Italy]. Med Lav (1992) 0.86
Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke. Arch Neurol (1998) 0.86
Trigeminal pain caused by a cerebellopontine-angle lipoma. Case report and review of the literature. J Neurosurg Sci (2001) 0.86
Limb-girdle muscular dystrophy with α-dystroglycan deficiency and mutations in the ISPD gene. Neurology (2013) 0.86
Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate. Mol Cell Biol (1999) 0.86
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Mov Disord (1997) 0.85
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. Brain Res Mol Brain Res (1997) 0.85
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (1997) 0.85
POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study. Neuromuscul Disord (2008) 0.85
Renal function and volume of infants born with a very low birth-weight: a preliminary cross-sectional study. Acta Paediatr (2010) 0.85
Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. Cancer Lett (1998) 0.84
High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm. Neurol Sci (2006) 0.84
[Mortality results in SENTIERI Project]. Epidemiol Prev (2011) 0.84
BamHI RFLP linked to the human urokinase gene. Nucleic Acids Res (1985) 0.84
Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke. J Neurol (1996) 0.84
Polyglucosan body disease simulating amyotrophic lateral sclerosis. Neurology (1993) 0.84
Duchenne muscular dystrophy and epilepsy. Neuromuscul Disord (2013) 0.83
Are there proliferating neuronal precursors in adult rat dorsal root ganglia? Neurosci Lett (2000) 0.83
Polymorphic variants in the human mitochondrial cytochrome b gene. Mol Genet Metab (1999) 0.83
Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. Diabetes (1999) 0.83
Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide. Br J Pharmacol (2010) 0.82
Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein. Oncogene (2010) 0.82
Drop-out rate in eating disorders: could it be a function of patient-therapist relationship? Eat Weight Disord (2007) 0.82
Very-long-chain acyl-coenzyme A dehydrogenase deficiency in a child with recurrent myoglobinuria. Neuromuscul Disord (1998) 0.82
Polymerase chain reaction products containing 5-methyldeoxycytidine: a microplate immunoquantitation method. Nucleic Acids Res (1994) 0.82
Scintigraphic demonstration of jugular obstruction in a case of Lemierre syndrome. Clin Nucl Med (1992) 0.81
Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency. Neuromuscul Disord (2012) 0.81